Charcot-Marie-Tooth Disease–Deafness Syndrome

Other names
Types
Causes
Symptoms
Diagnostic Tests
Non-pharmacological treatments (therapies and others)
Drug treatments (symptom-focused medical therapy)
Dietary molecular supplements
Regenerative, immune and stem-cell-related drugs and approaches
Surgical treatments
Prevention and lifestyle protection
When to see doctors
What to eat and what to avoid
Frequently asked questions (FAQs)

Charcot-Marie-Tooth disease–deafness syndrome is a very rare inherited nerve disease in which a person has both Charcot-Marie-Tooth (CMT) neuropathy and significant hearing loss, often from childhood or teenage years. CMT mainly damages the long nerves that go to the feet and hands, causing weak muscles, thin lower legs and hands, balance problems, and changes in feeling such as numbness or burning pain. In this syndrome, the nerves of the inner ear or the hearing pathways are also affected, so the person can have difficulty hearing speech, especially in noisy places, or can have almost complete deafness.Orpha+1

Charcot-Marie-Tooth disease–deafness syndrome is a very rare inherited nerve disorder in which a person has both Charcot-Marie-Tooth (CMT) peripheral neuropathy and permanent inner-ear (sensorineural) hearing loss, and in some families mild intellectual disability. In simple words, the long nerves to the feet, legs, hands and arms slowly stop working properly, and at the same time the tiny hair cells and nerves in the inner ear cannot send sound messages to the brain. MedlinePlus+1

CMT-deafness syndrome is usually caused by changes (mutations) in genes that are important for the myelin (protective covering) or structure of nerves. Because the cause is genetic, current treatment cannot “cure” the disease or fully reverse the nerve damage. Treatment focuses on protecting remaining nerve function, supporting walking and hand use, improving communication through hearing support, reducing pain and fatigue, and preventing complications such as falls, joint deformity, and social isolation. Care is usually given by a team that may include neurologists, ear-nose-throat (ENT) specialists, audiologists, physical and occupational therapists, and genetic counselors.Orpha+1

This syndrome belongs to the group of hereditary motor and sensory neuropathies, where both movement nerves (motor) and feeling nerves (sensory) are affected. Many patients develop weakness and wasting of the muscles in the feet and lower legs in childhood or teenage years, later involving the hands, together with balance problems, foot deformities, and walking difficulty. When deafness is present from birth or early life, speech development can be delayed and communication can be hard without hearing aids or sign language. NCBI+2MalaCards+2

Other names

Doctors and researchers use several other names for Charcot-Marie-Tooth disease–deafness syndrome. These names are useful to know because they may appear in reports or research papers, and they often describe the same or closely related conditions. NCBI+1

Charcot-Marie-Tooth disease–hearing loss–intellectual disability syndrome – this name stresses the three main features: neuropathy (CMT), hearing loss, and mild problems with learning or speech. NCBI
Deafness with Charcot-Marie-Tooth disease – a simple term used in some clinical reports when patients clearly have both CMT and sensorineural deafness. NCBI+1
Hereditary motor and sensory neuropathy with deafness and mental retardation – an older term used in early descriptions; today “intellectual disability” is preferred instead of “mental retardation.” NCBI+1
Charcot-Marie-Tooth disease and deafness (CMT1E) – this label is used when the syndrome is caused by certain mutations in the PMP22 gene and follows an autosomal dominant pattern; CMT1E is a demyelinating form of CMT with hearing loss. MalaCards+1
Autosomal dominant Charcot-Marie-Tooth neuropathy with deafness – used for families where one changed gene copy is enough to cause CMT plus deafness. MalaCards+1
Autosomal recessive hereditary demyelinating motor and sensory neuropathy with deafness – used when the disease appears only if both parents pass on a faulty gene, as described for the CMT–hearing loss–intellectual disability form. NCBI

Types

Because these conditions are very rare and involve many different genes, doctors think of “Charcot-Marie-Tooth disease–deafness syndrome” as a small group of related disorders, rather than one single disease. The types below are based on the main gene involved and the pattern of inheritance. MalaCards+2Wiley Online Library+2

Autosomal recessive CMT–deafness–intellectual disability type
This type is described by Orphanet and MedGen as a demyelinating neuropathy beginning in childhood with distal weakness and atrophy, congenital sensorineural deafness, and mild intellectual disability, often with almost complete loss of large myelinated fibers in sural nerve biopsy. Both gene copies must be faulty for the child to be affected. NCBI+1
PMP22-related CMT1E with deafness (autosomal dominant)
In this type, a mutation in the PMP22 gene, which makes a key protein in the myelin sheath of peripheral nerves, leads to a demyelinating CMT (type 1E) together with sensorineural hearing loss. A single changed gene copy is enough to cause the disease, and several specific PMP22 mutations have been reported in families with CMT and deafness. MalaCards+1
X-linked PRPS1-related CMT with deafness
Some families have changes in the PRPS1 gene on the X chromosome, which can cause a range of conditions from X-linked CMT to Arts syndrome and non-syndromic prelingual deafness. In the middle of this spectrum, affected males may show both CMT neuropathy and early-onset deafness, forming an X-linked CMT–deafness phenotype. PMC+1
CMT4D (NDRG1-related) with hearing loss
CMT type 4D is an autosomal recessive demyelinating neuropathy due to mutations in the NDRG1 gene. Many patients with this subtype develop sensorineural hearing impairment, sometimes progressing to deafness in early to mid-adulthood, together with severe slowing of nerve conduction velocities. Orpha+1
Other CMT subtypes where hearing loss is a common feature
Research has shown that hearing loss can occur in several inherited peripheral neuropathies involving genes such as MPZ, SH3TC2, NEFL, ABHD12, and also in common CMT1A due to PMP22 duplication, where “hidden” hearing problems may be present even when the audiogram looks normal. These cases may clinically resemble CMT–deafness syndrome. Wiley Online Library+2Charcot-Marie-Tooth Disease+2
Syndromic neuropathies with neuropathy, deafness, and other features
Some rare disorders combine peripheral neuropathy and hearing loss with additional signs such as ataxia, vision problems, or endocrine issues. Examples include PHARC (polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract) due to ABHD12 mutations. Although not always labeled as CMT, they overlap clinically with CMT–deafness syndromes. Wiley Online Library+1

Causes

In this section, “cause” means the underlying medical reason why a person develops Charcot-Marie-Tooth disease–deafness syndrome. Most causes are specific gene changes that affect myelin or nerve cell function, leading to both neuropathy and hearing loss. MalaCards+1

Pathogenic PMP22 mutations (CMT1E)
Single-letter or small changes in the PMP22 gene sequence can disrupt the structure or amount of PMP22 protein in Schwann cells. This leads to unstable myelin around peripheral nerves, slowing electrical signals to muscles and sensory receptors, and may also disturb auditory nerve or cochlear myelin, causing sensorineural hearing loss. MalaCards+1
PMP22 gene dosage abnormalities
While duplication of PMP22 causes classic CMT1A and deletion causes HNPP, some atypical rearrangements or complex copy number variants can give a mixed picture with neuropathy and hearing problems. Abnormal gene dosage changes how much PMP22 protein is produced, harming both limb and auditory nerve function. MalaCards+1
Autosomal recessive NDRG1 mutations (CMT4D)
When both copies of the NDRG1 gene are faulty, Schwann cell differentiation and myelination are impaired. Over time this causes severe demyelinating neuropathy with very slow nerve conduction, and in many patients the cochlear nerve is also affected, leading to progressive hearing impairment and sometimes deafness. Orpha+1
PRPS1 mutations on the X chromosome
PRPS1 is involved in nucleotide synthesis, important for cell energy and repair. Changes in this gene can damage both peripheral nerves and the auditory system. In some families, affected males develop a combination of CMT-like neuropathy and early-onset sensorineural deafness, forming a CMT–deafness continuum. PMC
MPZ (myelin protein zero) gene mutations
MPZ encodes a major structural protein of peripheral nerve myelin. Certain dominant mutations can cause demyelinating or axonal CMT with variable severity. In some patients, MPZ mutations have also been linked to hearing loss, probably by disturbing similar myelin structures in the auditory nerve. Synapse+1
GJB1 (connexin-32) gene mutations (CMT1X)
GJB1 encodes connexin-32, a gap junction protein in Schwann cells. Mutations cause X-linked CMT1X, and animal and human studies show that similar connexin channels are important in the inner ear. When they fail, both peripheral nerve conduction and cochlear ion balance are disturbed, leading to neuropathy and hearing loss. Charcot-Marie-Tooth Disease+1
SH3TC2 mutations (recessive demyelinating neuropathy with hearing loss)
SH3TC2 is involved in endocytic traffic in Schwann cells. Recessive mutations typically cause early-onset demyelinating neuropathy. Hearing loss has been reported in some individuals, suggesting that the protein is also important in the auditory nerve or inner-ear supporting cells. Wiley Online Library
NEFL gene mutations
NEFL encodes the neurofilament light chain, a key structural component of axons. Missense mutations can cause axonal CMT. Since neurofilaments are present in many neuronal types, changes can affect both peripheral nerves and auditory pathways, contributing to sensorineural hearing loss along with neuropathy. Wiley Online Library+1
ABHD12 mutations (PHARC and related phenotypes)
ABHD12 is a serine hydrolase linked with lipid metabolism in the nervous system. Biallelic loss-of-function mutations cause PHARC, a syndrome with polyneuropathy and hearing loss. In some patients the neuropathy resembles CMT, so ABHD12 disease can be considered within the broad CMT–deafness spectrum. Wiley Online Library+1
Mitochondrial dysfunction affecting peripheral and auditory nerves
Some mitochondrial DNA or nuclear gene defects interfere with energy production. Nerves with long axons, such as those in the legs and the cochlear nerve, need constant energy. When mitochondria fail, axons degenerate, leading to peripheral neuropathy and hearing loss within the same individual. MDPI+1
Other rare CMT gene mutations with reported hearing loss
More than 100 genes have been linked to CMT, and case reports show that hearing problems can appear in several of them, including PRX, GDAP1, and others. When both neuropathy and deafness are present, clinicians may group them as CMT–deafness cases even if the exact gene is uncommon. Synapse+1
Demyelination of auditory nerve fibers
In demyelinating forms of CMT, Schwann cell damage can also affect the auditory branch of the VIIIth cranial nerve. Loss of myelin slows or blocks sound signal transmission, causing difficulty understanding speech, especially in noisy environments, and eventually measurable hearing loss or deafness. Nature+1
Axonal degeneration in long sensory and motor nerves
In mainly axonal CMT subtypes, direct loss of nerve fibers reduces signal strength to muscles and sensory organs. When similar degeneration occurs in the cochlear nerve, the inner ear cannot properly send sound information to the brain, leading to sensorineural hearing loss together with limb neuropathy. MedlinePlus+1
Loss of large myelinated fibers (sural nerve and others)
Pathology studies in CMT–deafness–intellectual disability syndrome show almost complete absence of large myelinated sensory fibers in sural nerve biopsies. These large fibers are critical for vibration sense, joint position sense, and fast nerve conduction, and their loss explains both the neuropathy and some balance problems that worsen deafness-related instability. NCBI+1
Disruption of cochlear hair cell function
Some gene defects may directly harm cochlear hair cells or their supporting cells. When hair cells cannot convert sound vibrations into electrical signals, the person develops congenital or early-life deafness, which may coexist with CMT if the same gene is expressed in both peripheral nerves and the inner ear. Charcot-Marie-Tooth Association+1
Abnormal ion channel or gap junction function in the inner ear
Genes like GJB1, which affect connexin proteins, may also disturb potassium recycling in the cochlea. Proper ion flow is essential for hearing. When these pathways fail, hearing loss appears alongside peripheral myelin damage, giving a combined CMT–deafness phenotype. Wiley Online Library+1
Autosomal recessive inheritance within consanguineous families
In some families where parents are related, children have a higher chance of inheriting the same faulty recessive gene from both sides. This explains several reported cases of CMT–deafness–intellectual disability syndrome with demyelinating neuropathy and congenital deafness. NCBI+1
Autosomal dominant inheritance with variable expressivity
In PMP22-related CMT1E and some other dominant forms, not all carriers have the same severity of neuropathy or hearing loss. Some family members may mainly show CMT, while others also have marked deafness, which still comes from the same underlying dominant mutation. MalaCards+1
X-linked inheritance affecting mainly males
PRPS1 and GJB1 mutations are X-linked. Males (with one X chromosome) tend to be more severely affected, often showing both neuropathy and hearing loss, while female carriers may have milder CMT, slight hearing problems, or be almost asymptomatic. PMC+1
Complex or unknown genetic mechanisms
Even with modern testing, some families with clear CMT and deafness have no identified mutation yet. This suggests that more genes and mechanisms remain to be discovered, including regulatory variants, structural rearrangements, or combined effects of multiple rare changes. ScienceDirect+1

Symptoms

Symptoms of Charcot-Marie-Tooth disease–deafness syndrome combine those of CMT neuropathy and sensorineural hearing loss, and sometimes mild intellectual disability. Not every patient will have all symptoms, and severity can vary even within one family. NCBI+2MalaCards+2

Distal muscle weakness in feet and lower legs
The earliest sign is often weakness of the small muscles of the feet and ankles, making it hard to stand on toes or heels and causing frequent tripping. This results from slow or blocked signals in the long motor nerves to the legs. MalaCards+1
Muscle wasting (atrophy) of calves and feet
Over time, weak muscles shrink because they are not properly stimulated by nerves. The lower legs can appear thin and “inverted champagne bottle” shaped, a typical feature of CMT. MalaCards+1
Foot deformities (pes cavus and hammertoes)
Imbalance between weak and stronger muscles pulls the foot into a high-arched position, called pes cavus. Toes may curl (hammertoes). These deformities can cause pain, pressure sores, and difficulty finding comfortable shoes. MalaCards+1
Gait instability and frequent falls
Weak ankles, loss of feeling in the feet, and foot deformities make walking unstable. Patients may lift their legs higher than normal to avoid dragging the toes (steppage gait), and they may fall often, especially in the dark or on uneven ground. MedlinePlus+1
Weakness of hands and intrinsic hand muscles
As the disease progresses, the small muscles of the hands can become weak. Patients may have trouble with buttons, writing, or holding small objects, and the hands can look thin with visible bones and tendons. MalaCards+1
Loss of vibration and position sense in feet
Damage to large sensory fibers reduces the ability to feel vibration and to know where the feet are without looking. This worsens balance and contributes to unsteady walking and difficulty standing still with eyes closed. NCBI+1
Reduced or absent tendon reflexes
Deep tendon reflexes, such as at the ankles and knees, may be weak or absent because the reflex arc needs healthy nerves and myelin. This is a common neurological sign in CMT and helps doctors suspect a peripheral neuropathy. neuromuscular.wustl.edu+1
Neuropathic pain or abnormal sensations
Some patients experience burning, tingling, or electric-shock-like sensations in their feet or hands. Others report numbness or “walking on cotton.” These abnormal feelings come from damaged sensory nerve fibers. MedlinePlus+1
Congenital or early-onset sensorineural deafness
Many patients with CMT–deafness–intellectual disability syndrome are born with severe to profound sensorineural hearing loss. Because the inner ear or auditory nerve is affected, hearing aids may help only partially and early detection is very important for communication development. NCBI+1
Progressive hearing loss in childhood or early adulthood
In some subtypes like CMT4D or CMT1E, hearing is normal at birth but slowly worsens over years. Patients may first struggle to hear high-frequency sounds or understand speech in noise, then later develop more general hearing loss. Orpha+1
Difficulty understanding speech in noisy places
Even when basic hearing tests look almost normal, people with CMT1A or related forms can have serious difficulty following conversation in a busy room or classroom. This “hidden hearing loss” is due to subtle damage in auditory nerve fibers and neural processing. Nature+1
Delayed speech and language development
Children with congenital deafness often begin to babble, speak, or understand spoken words later than peers. Without hearing aids, cochlear implants, or sign language, they may not develop normal spoken language, leading to communication challenges. NCBI+1
Mild intellectual disability or learning difficulties
In the recessive CMT–deafness–intellectual disability form, some children have mild cognitive impairment, especially in language-based tasks. This may be related to early sensory deprivation plus direct brain or nerve involvement. NCBI+1
Balance problems and increased risk of falls
The combination of neuropathy, loss of joint position sense, foot deformities, and poor hearing makes balance particularly difficult. Patients may sway when standing and are at higher risk for fall-related injuries. NCBI+1
Fatigue and reduced endurance
Everyday tasks can be tiring because muscles are weak and nerves transmit signals inefficiently. Constant effort to maintain balance, walk, or communicate despite hearing problems adds to overall fatigue and can limit school or work participation. scientificarchives.com+1

Diagnostic Tests

Physical examination tests

Physical examination is the first and most important step in diagnosing Charcot-Marie-Tooth disease–deafness syndrome. A careful neurological and ear examination gives many clues that guide further investigations. MedlinePlus+1

General neurological examination
The doctor checks muscle bulk, tone, strength, reflexes, coordination, and gait. Typical findings in CMT are distal weakness and wasting, reduced reflexes, steppage gait, and preserved or slightly affected proximal muscles, suggesting a length-dependent neuropathy. neuromuscular.wustl.edu+1
Focused foot and ankle examination
The clinician looks for high arches, hammertoes, ankle instability, and calluses. These signs support a chronic neuropathy and help distinguish CMT from other causes of weakness. They also guide decisions about orthotic devices or surgery. MedlinePlus+1
Sensory examination of vibration and joint position
Using a tuning fork and gentle movement of toes and ankles, the examiner checks vibration sense and position sense. Loss of these modalities in a stocking pattern supports involvement of large myelinated fibers, as described in CMT–deafness–intellectual disability syndrome. NCBI+1
Cranial nerve and otologic examination
The doctor tests facial movements, eye movements, and especially hearing using whispered voice, tuning forks, or simple bedside tests. Finding both distal neuropathy signs and clear hearing impairment raises suspicion for a combined CMT–deafness syndrome. MedlinePlus+1
Developmental and cognitive assessment in children
For pediatric patients, clinicians observe speech, language, learning, and overall development. Delayed speech and mild intellectual disability together with neuropathy and deafness point toward the specific recessive CMT–deafness–intellectual disability subtype. NCBI+1

Manual clinical tests

Manual tests are simple bedside procedures that use hands or simple tools to evaluate strength, function, and balance without machines. They are very useful in routine follow-up. neuromuscular.wustl.edu+1

Manual muscle testing of distal muscles
The examiner asks the patient to move ankles, toes, wrists, and fingers against resistance and grades strength on a 0–5 scale. In CMT, distal muscles are weaker than proximal ones, and changes over time show disease progression. neuromuscular.wustl.edu+1
Functional walking tests (for example, 10-meter walk)
The patient is timed while walking a short distance at a comfortable speed. This simple test reflects overall mobility, balance, and endurance, and can show how much orthoses or rehabilitation are helping. scientificarchives.com+1
Romberg test for balance
The patient stands with feet together and then closes the eyes. Increased swaying or falling suggests impaired proprioception from large fiber neuropathy. When this is combined with deafness, the balance challenge is even greater. NCBI+1
Hand function tests (grip and pinch)
The clinician asks the patient to squeeze the examiner’s fingers or a dynamometer and to pinch objects. Weak grip and pinch in the presence of foot weakness support a generalized length-dependent neuropathy such as CMT. MedlinePlus+1
Simple bedside hearing tests (Weber and Rinne)
A tuning fork is used to compare sound conduction through bone and air. In CMT–deafness syndromes, patterns usually show sensorineural hearing loss, which helps distinguish inner-ear or nerve problems from middle-ear disease. Wiley Online Library+1

Laboratory and pathological tests

Lab and pathological tests help confirm the diagnosis, rule out other causes, and sometimes show characteristic nerve changes in this syndrome. NCBI+1

Basic blood tests (glucose, thyroid, vitamin levels)
Standard tests look for acquired causes of neuropathy such as diabetes, thyroid disease, or vitamin B12 deficiency. Normal results make an inherited form like CMT more likely when there is a compatible family history and clinical picture. MedlinePlus+1
Genetic testing panels for CMT
Next-generation sequencing panels analyze many known CMT genes, including PMP22, MPZ, GJB1, NDRG1, PRPS1, and others. Identifying a pathogenic variant that matches the clinical features confirms the specific CMT–deafness subtype and guides counseling. Synapse+1
Copy number analysis of PMP22 (MLPA or array)
Techniques such as MLPA or microarray look for duplications, deletions, or other structural changes in the PMP22 region. These tests are essential when CMT1A, HNPP, or CMT1E-like phenotypes with deafness are suspected. MalaCards+1
Targeted testing for suspected single genes (for example PRPS1)
If the family pattern suggests X-linked inheritance or clinical features fit a known syndrome, sequencing of a single gene such as PRPS1 or NDRG1 may be ordered. This approach is useful in families with many affected members. PMC+1
Sural nerve biopsy (selected cases)
In uncertain situations, a small sensory nerve from the lower leg may be removed and examined under the microscope. In CMT–deafness–intellectual disability syndrome, biopsies show severe loss of large myelinated fibers, providing strong evidence of a hereditary demyelinating neuropathy. NCBI+1
Cerebrospinal fluid (CSF) analysis (to exclude inflammatory neuropathy)
A lumbar puncture can check for high protein or inflammatory cells that would suggest acquired conditions like chronic inflammatory demyelinating polyneuropathy (CIDP). Normal CSF supports a genetic CMT diagnosis rather than an immune cause. neuromuscular.wustl.edu+1

Electrodiagnostic tests

Electrodiagnostic studies are key tools to show the pattern and severity of neuropathy in CMT–deafness syndromes and to separate demyelinating from axonal forms. neuromuscular.wustl.edu+1

Nerve conduction studies (NCS)
Small electrodes stimulate peripheral nerves and record the responses. Demyelinating CMT shows very slow conduction velocities and prolonged latencies, while axonal forms show low amplitudes. In CMT–deafness–intellectual disability syndrome and many PMP22-related cases, markedly reduced motor and sensory conduction velocities are typical. NCBI+1
Electromyography (EMG)
A fine needle electrode is inserted into muscles to record electrical activity at rest and during contraction. EMG in CMT shows chronic denervation and re-innervation patterns, confirming a neurogenic rather than muscle disorder and helping exclude primary myopathies. neuromuscular.wustl.edu+1
Auditory brainstem response (ABR) testing
ABR measures electrical responses in the brainstem after sound clicks. Abnormal or absent waves in patients with CMT and hearing loss indicate involvement of the auditory nerve or pathways, supporting a sensorineural cause and linking deafness to the neuropathy. Wiley Online Library+1
Otoacoustic emissions (OAE)
OAE tests the function of outer hair cells in the cochlea by recording tiny sounds they generate. Absent OAEs together with abnormal ABR support cochlear or auditory nerve damage as seen in hereditary CMT–deafness syndromes. Charcot-Marie-Tooth Association+1

Imaging tests

Imaging is not always required but can help exclude other problems and, in research settings, explore nerve and brain involvement in CMT–deafness syndromes. scientificarchives.com+1

MRI of the brain and internal auditory canals
Magnetic resonance imaging checks for structural lesions, tumors, or malformations that could cause hearing loss. Normal MRI in a person with CMT and deafness supports a genetic inner-ear or nerve cause rather than a mass or inflammation. Wiley Online Library+1
MRI of the spine and peripheral nerves (neurography)
High-resolution MRI can show thickened or enlarged peripheral nerves and sometimes altered signal in nerve roots or plexuses. These changes are consistent with hereditary neuropathy and may be seen in some CMT subtypes. neuromuscular.wustl.edu+1
CT of the temporal bone (selected cases)
Computed tomography can evaluate the bony structures of the inner and middle ear. Although CT is often normal in genetic sensorineural deafness, it can exclude malformations, otosclerosis, or other treatable causes, helping to focus attention on the genetic neuropathy. Charcot-Marie-Tooth Association+1
X-rays or weight-bearing imaging of feet
Simple X-rays show the degree of foot deformity such as pes cavus or hammertoes. This information is useful for planning orthopedic management, custom orthoses, or corrective surgery in patients with advanced CMT–related foot problems. MedlinePlus+1

Non-pharmacological treatments (therapies and others)

1. Individualized physical therapy
Description: Physical therapy is one of the most important non-drug treatments in Charcot-Marie-Tooth disease–deafness syndrome. A trained therapist designs safe exercises to keep the muscles of the legs, hips, trunk, and sometimes arms as strong and flexible as possible. Sessions often include gentle strengthening, stretching, balance practice, and walking training. Regular physical therapy can slow muscle tightening and joint stiffness and can also help a person feel more in control of their body.Mayo Clinic+1
Purpose: To keep mobility, reduce contractures, and support independence in walking and daily activities.
Mechanism: Repeated movement and strengthening help the remaining nerve-muscle connections work more efficiently and reduce secondary weakness from disuse.

2. Occupational therapy for hand and daily tasks
Description: Occupational therapists teach practical ways to manage daily life, such as dressing, writing, using a phone, or cooking, when hand muscles are weak or fingers are numb. They may suggest special tools like built-up pens, large-handled cutlery, zipper pulls, and easy-grip jar openers. They also advise on how to set up the home and school or work environment so that tasks need less fine finger control and less grip strength.Muscular Dystrophy Association
Purpose: To help people remain independent and safe in self-care, study, and work despite weakness and sensory loss.
Mechanism: Adapting tools and techniques reduces the physical load on weak muscles and bypasses lost sensation, making tasks achievable.

3. Stretching and range-of-motion exercises
Description: Gentle daily stretching of ankles, knees, hips, fingers, and wrists is important in CMT because weak muscles and unbalanced pull around joints easily lead to tight tendons and contractures. A therapist teaches safe stretches that can be done at home, sometimes using straps or a wall for support. Over time, stretching keeps joints more flexible, makes walking smoother, and can reduce aching from stiff muscles.Mayo Clinic+1
Purpose: To prevent fixed deformities and reduce stiffness and pain in muscles and joints.
Mechanism: Slow stretching of muscles and tendons maintains their length and reduces abnormal joint positions caused by uneven muscle strength.

4. Strengthening and endurance training
Description: Carefully planned strengthening with light resistance, such as elastic bands or body-weight exercises, can help preserve muscle power in parts of the legs and arms that are less affected. Low-impact endurance activities like stationary cycling, swimming, or walking in water can keep the heart and lungs fit without over-loading fragile feet. Exercise must be moderate and supervised, because over-exertion may worsen fatigue or cause injuries.Mayo Clinic+1
Purpose: To preserve muscle power, reduce fatigue in daily life, and support overall health.
Mechanism: Moderate, repeated effort stimulates surviving nerve-muscle units and improves energy use in muscle cells, without directly changing the underlying genetic problem.

5. Balance and gait training
Description: Many people with CMT-deafness have difficulty with balance because of weak foot and ankle muscles, reduced feeling in the feet, and sometimes vestibular (inner ear) dysfunction linked to hearing loss. Therapists use special balance exercises, such as standing on different surfaces or walking along lines, and practice safe ways to turn and climb stairs. Training may also involve learning to use assistive devices like canes or trekking poles.Charcot-Marie-Tooth Association+1
Purpose: To lower the risk of falls and improve confidence when walking indoors and outdoors.
Mechanism: Repeated balance tasks help the brain use visual and remaining sensory information more effectively and teach safer movement patterns.

6. Ankle-foot orthoses (AFOs) and bracing
Description: Light plastic or carbon-fiber braces that support the ankle and foot are widely used in CMT. They can keep the foot from dropping down, reduce ankle rolling, and make the step more stable. For someone with deafness and poor balance, good bracing is especially important because they cannot always rely on hearing to detect environmental hazards. Orthotists custom-fit the braces to avoid pressure sores and to match the person’s shoes.Charcot-Marie-Tooth Association+1
Purpose: To improve walking safety, increase endurance, and prevent ankle sprains and falls.
Mechanism: AFOs hold the ankle in a neutral position and store energy during the step, compensating for weakness of the muscles that lift and stabilize the foot.

7. Custom footwear and insoles
Description: Shoes with firm heel counters, wide toe boxes, and cushioned soles help protect feet that are weak and numb. Custom insoles can support high arches or flattening and can redistribute pressure away from bony areas that are at risk of calluses and ulcers. Rocker-bottom soles may help when ankle motion is limited.Mayo Clinic+1
Purpose: To protect skin, reduce pain in the feet, and make walking more secure and less tiring.
Mechanism: Proper footwear spreads forces across the sole and reduces pressure points, which is important when sensation is reduced and injuries may go unnoticed.

8. Assistive walking devices
Description: Canes, crutches, or walkers can give extra support to people whose leg weakness or balance problems make falls more likely, especially in low-light or crowded settings where hearing loss also makes awareness difficult. A therapist teaches correct height and technique to prevent wrist or shoulder strain. Using such devices early is not a failure; it is a safety strategy.Muscular Dystrophy Association
Purpose: To reduce falls, support safe mobility, and allow longer walking distances.
Mechanism: These devices widen the base of support and allow the arms to share the load that would otherwise be carried only by weak legs.

9. Hand splints and wrist supports
Description: Soft or semi-rigid splints can stabilize weak wrists and thumbs, making it easier to grip objects, type, or use sign language or hand gestures for communication when hearing is poor. Occupational therapists adjust splints so that they support without blocking needed motion.Muscular Dystrophy Association
Purpose: To improve hand function and reduce joint strain in weak or unstable wrists and fingers.
Mechanism: Splints support joints in a neutral position and reduce abnormal movement patterns that can cause pain and further deformity.

10. Hearing aids and assistive listening devices
Description: For many people with CMT-related hearing loss, digital hearing aids that amplify speech and reduce background noise are very helpful. Other tools, such as remote microphones in classrooms, FM systems, or Bluetooth streaming from phones and televisions, can improve understanding in noisy places. Choices depend on the pattern of hearing loss and personal needs, so careful testing by an audiologist is essential.Charcot-Marie-Tooth Association+1
Purpose: To improve communication, education, work, and social interaction.
Mechanism: Hearing aids raise the loudness of speech and use sound processing to make speech clearer, partly compensating for the reduced function of auditory nerves or hair cells.

11. Cochlear implants or other auditory implants
Description: In people with severe or profound sensorineural hearing loss who get little benefit from hearing aids, cochlear implants may be considered. These devices convert sound into electrical signals delivered directly to the inner ear nerve fibers. For some rare CMT-related hearing problems, electrical stimulation at the brainstem level may be discussed in highly specialized centers. Decisions require detailed testing and counselling.Charcot-Marie-Tooth Association+1
Purpose: To restore access to sound and speech when conventional amplification no longer helps.
Mechanism: Implanted electrodes bypass damaged hair cells and directly stimulate the auditory nerve, allowing the brain to interpret sound patterns after rehabilitation.

12. Auditory rehabilitation and speech therapy
Description: After getting hearing aids or implants, many people need training to understand new sound patterns. Speech-language therapists and audiologists use listening exercises, lip-reading training, and communication strategies, such as facing the speaker and improving lighting. They may also teach family members how to speak clearly and support communication.Charcot-Marie-Tooth Association+1
Purpose: To maximize benefit from hearing devices and reduce communication stress.
Mechanism: Structured practice helps the brain adapt to altered sound signals and improves the use of visual cues, making overall understanding better.

13. Sign language and visual communication methods
Description: Some people with CMT-deafness choose to learn sign language, cued speech, or written communication systems. These methods can become the main language or an important backup in noisy settings or when devices cannot be used. Learning is easier with early start but can be helpful at any age.Charcot-Marie-Tooth Association+1
Purpose: To provide a reliable way to communicate even when hearing is very limited.
Mechanism: Visual communication bypasses the damaged auditory system and relies on eye-hand coordination, which can be adapted using larger, slower signs if hand weakness is present.

14. Psychological counselling and peer support
Description: Living with a progressive nerve and hearing disorder can cause sadness, anxiety, or social withdrawal. Counseling with a psychologist who understands chronic illness can help people process emotions, build coping strategies, and prevent depression. Peer groups and CMT or deafness associations also provide community and practical tips.Muscular Dystrophy Association+1
Purpose: To protect mental health, self-esteem, and social participation.
Mechanism: Talking therapies such as cognitive-behavioral therapy (CBT) change unhelpful thought patterns and teach coping skills, reducing distress and improving quality of life.

15. Pain psychology and relaxation training
Description: Chronic nerve pain and muscle cramps are common in CMT and can be worsened by stress. Pain psychologists teach relaxation, breathing exercises, mindfulness, and distraction methods to help people cope with pain alongside medical treatments. These skills are particularly important when communication difficulties make it hard to describe symptoms.Muscular Dystrophy Association+1
Purpose: To reduce the suffering caused by pain and improve sleep and daily function.
Mechanism: Relaxation and CBT techniques influence how the brain interprets pain signals and reduce the emotional “volume” of pain even if the nerve damage stays the same.

16. Vocational and educational rehabilitation
Description: Specialists in vocational rehabilitation help teenagers and adults choose careers and training that match their abilities and limitations. They may arrange workplace accommodations such as ergonomic chairs, voice-to-text software, or captioned phones, and help with legal protections for people with disabilities.Muscular Dystrophy Association
Purpose: To support long-term employment, education, and financial independence.
Mechanism: Matching job demands to abilities and providing reasonable adaptations reduce physical strain and stress and make staying in work or school more realistic.

17. Home safety and fall-prevention modifications
Description: Simple changes at home, such as removing loose rugs, adding grab bars in bathrooms, improving lighting, and using non-slip shoes, can greatly lower fall risk in someone with weak feet and limited hearing. If balance is very poor, stair rails on both sides or stairlifts may be recommended.Mayo Clinic+1
Purpose: To prevent fractures, head injuries, and fear of falling.
Mechanism: Environmental changes remove tripping hazards and provide extra points of support, compensating for neuromuscular and sensory deficits.

18. Skin and foot-care programs
Description: Because many people with CMT have reduced feeling in their feet, small cuts, blisters, or pressure sores can go unnoticed and become serious infections. Regular foot checks, careful nail care, moisturizing, and early treatment of calluses and ulcers are essential. Podiatrists can teach safe self-care and perform high-risk procedures.Mayo Clinic+1
Purpose: To prevent chronic ulcers, infections, and in extreme cases amputations.
Mechanism: Early detection and treatment of minor skin problems stops them from progressing while protective routines reduce new injuries.

19. Genetic counselling and family planning support
Description: Because this syndrome is inherited, families often want to know the chance that children will be affected. Genetic counsellors explain the pattern of inheritance, discuss genetic testing, and talk about options such as prenatal testing or assisted reproduction with pre-implantation genetic testing, where legally and ethically appropriate.Orpha
Purpose: To give families clear information for informed reproductive decisions and emotional preparation.
Mechanism: Understanding the genetic risk and available options helps reduce anxiety and allows planning for medical follow-up of relatives.

20. Patient education and advocacy organizations
Description: Learning about CMT, hearing loss, and rights for people with disabilities empowers patients and families. Organizations such as CMT foundations and deaf or hard-of-hearing associations provide educational materials, webinars, and advocacy for better care and research.Charcot-Marie-Tooth Association+1
Purpose: To support self-management and connect people with expert resources and community.
Mechanism: Reliable information and community support improve adherence to treatment, encourage healthy behaviors, and reduce isolation.

Drug treatments (symptom-focused medical therapy)

Important note: The medicines below are used to treat symptoms such as nerve pain, mood problems, or muscle stiffness in Charcot-Marie-Tooth disease–deafness syndrome. Most are not specifically approved for this rare syndrome but are used based on evidence from other neuropathic or chronic conditions. Exact choice and dose must always be decided by a doctor who knows the patient’s age, kidney and liver function, other medicines, and local guidelines.

1. Gabapentin
Description: Gabapentin is an anti-seizure medicine widely used to treat neuropathic (nerve) pain such as burning, shooting, or tingling pain in the feet and legs. It can also reduce sleep disturbance and anxiety linked to pain.FDA Access Data+1
Drug class: Antiepileptic / neuropathic pain agent.
Typical adult dosage and time: Often started at low doses (for example 300 mg at night) and slowly increased to divided doses during the day and night as tolerated, following the FDA label for neuropathic pain indications.FDA Access Data+1
Purpose: To reduce nerve pain and improve sleep and function.
Mechanism: Gabapentin binds to the α2δ subunit of voltage-gated calcium channels in the nervous system, reducing the release of excitatory neurotransmitters and lowering abnormal nerve firing.
Main side effects: Drowsiness, dizziness, weight gain, swelling in legs, and sometimes mood changes; sudden stopping can cause withdrawal symptoms.FDA Access Data+1

2. Pregabalin
Description: Pregabalin is similar to gabapentin but more predictable in absorption. It is approved for several neuropathic pain conditions and can be useful for painful CMT-related neuropathy.FDA Access Data+1
Drug class: Antiepileptic / neuropathic pain agent.
Typical adult dosage and time: Often started around 150 mg per day in divided doses and may be increased over a week according to response and tolerability, within FDA-approved dose ranges.FDA Access Data+1
Purpose: To control burning and shooting nerve pain and improve sleep.
Mechanism: Like gabapentin, it binds to α2δ subunits of calcium channels, reducing abnormal nerve excitability.
Main side effects: Dizziness, drowsiness, blurred vision, weight gain, and swelling; it can also cause mood or behavior changes in some people.FDA Access Data+1

3. Duloxetine
Description: Duloxetine is an antidepressant that is also approved for diabetic neuropathic pain and chronic musculoskeletal pain. It can be useful if someone with CMT also has low mood or anxiety, which is common in chronic illness.FDA Access Data+2FDA Access Data+2
Drug class: Serotonin–norepinephrine reuptake inhibitor (SNRI) antidepressant.
Typical adult dosage and time: Often 30–60 mg once daily, adjusted according to labelled indications and tolerability.FDA Access Data
Purpose: To reduce neuropathic pain and treat depression or anxiety symptoms.
Mechanism: Increases levels of serotonin and norepinephrine in pain-modulating pathways in the spinal cord and brain, dampening pain signals and improving mood.
Main side effects: Nausea, dry mouth, sleep changes, sweating, and small increases in blood pressure; abrupt stopping can cause withdrawal symptoms.FDA Access Data

4. Amitriptyline
Description: Amitriptyline is an older antidepressant that is widely used at low doses for chronic neuropathic pain and to help with sleep. It is often taken at night because it can be sedating.PMC+1
Drug class: Tricyclic antidepressant.
Typical adult dosage and time: Pain treatment usually uses lower doses than depression, for example 10–25 mg at night, increased slowly as needed and tolerated.nhs.uk
Purpose: To decrease nerve pain and improve sleep quality.
Mechanism: Blocks reuptake of serotonin and norepinephrine and has additional effects on sodium and other channels that reduce pain transmission.
Main side effects: Dry mouth, constipation, blurred vision, drowsiness, weight gain, and, rarely, heart rhythm changes.PMC+1

5. Naproxen
Description: Naproxen is a non-steroidal anti-inflammatory drug (NSAID) used for muscle and joint pain, which may occur from abnormal walking or joint deformities in CMT. It does not treat nerve damage but can relieve musculoskeletal aches and cramps.FDA Access Data+2FDA Access Data+2
Drug class: NSAID analgesic.
Typical adult dosage and time: Dose and schedule follow the product label, often taken with food to protect the stomach.FDA Access Data+2FDA Access Data+2
Purpose: To reduce inflammatory and mechanical pain in joints and soft tissues.
Mechanism: Inhibits cyclo-oxygenase (COX) enzymes, lowering prostaglandin production and thus inflammation and pain.
Main side effects: Risk of stomach ulcers, bleeding, kidney problems, and cardiovascular events, especially with long-term or high-dose use.FDA Access Data+2FDA Access Data+2

6. Tramadol
Description: Tramadol is a centrally acting pain medicine used for moderate to severe pain not controlled by other drugs. It may be considered for short periods in severe neuropathic or musculoskeletal pain, under strict medical supervision.FDA Access Data+2FDA Access Data+2
Drug class: Opioid-like analgesic with SNRI properties.
Typical adult dosage and time: Given by mouth in doses that follow FDA labeling, with limits to reduce risk of dependence and side effects.FDA Access Data
Purpose: To control pain episodes that seriously limit movement or sleep when safer options are not enough.
Mechanism: Weakly activates opioid receptors and inhibits reuptake of serotonin and norepinephrine, reducing pain signaling.
Main side effects: Nausea, dizziness, constipation, drowsiness, risk of dependence, and risk of serious breathing and serotonin-related problems if misused.FDA Access Data+1

7. Baclofen
Description: Baclofen helps treat muscle stiffness and spasms, which may affect some people with neuromuscular disorders. If CMT causes increased muscle tone or painful spasms, baclofen may be used.FDA Access Data+1
Drug class: Muscle relaxant and antispastic agent.
Typical adult dosage and time: Usually started at low doses several times daily and increased slowly according to FDA labeling and patient response.FDA Access Data+1
Purpose: To reduce spasticity or severe muscle cramping that interferes with function or sleep.
Mechanism: Acts as a GABA-B receptor agonist in the spinal cord, decreasing excitatory signals to muscles.
Main side effects: Drowsiness, weakness, dizziness, and, if stopped suddenly at high doses, risk of withdrawal symptoms including seizures.FDA Access Data+1

8. Sertraline
Description: Sertraline is a commonly used antidepressant of the SSRI group. Chronic illness, pain, and communication barriers from deafness increase the risk of depression and anxiety, so treatment of mood disorders is often part of care.FDA Access Data+2FDA Access Data+2
Drug class: Selective serotonin reuptake inhibitor (SSRI).
Typical adult dosage and time: Often started at 25–50 mg per day, adjusted in line with FDA labeling and clinical response.FDA Access Data+1
Purpose: To treat depression, anxiety, or obsessive symptoms that worsen coping with CMT-deafness syndrome.
Mechanism: Increases serotonin levels at nerve synapses in the brain, helping to normalize mood circuits.
Main side effects: Nausea, diarrhea, insomnia or sleepiness, sexual side effects, and rare risk of serotonin syndrome or increased suicidal thoughts in young people early in therapy.FDA Access Data

9. Midodrine
Description: Some people with neuropathies develop orthostatic hypotension (a drop in blood pressure when standing), causing dizziness or fainting. Midodrine is used for symptomatic orthostatic hypotension in selected patients.FDA Access Data+2FDA Access Data+2
Drug class: Alpha-1 adrenergic agonist.
Typical adult dosage and time: Tablets are usually taken three times daily during daytime according to label instructions.FDA Access Data
Purpose: To reduce dizziness and fainting related to low standing blood pressure.
Mechanism: Stimulates alpha-1 receptors in blood vessels, causing constriction and increasing blood pressure when upright.
Main side effects: Goosebumps, scalp tingling, urinary retention, and supine hypertension, so lying blood pressure must be monitored.FDA Access Data+1

10. Vitamin D preparations
Description: Vitamin D is often prescribed when blood levels are low, especially in people with limited mobility, because it supports bone health. People with neuropathy and deafness may fall more and benefit from stronger bones.Mayo Clinic+1
Drug class: Vitamin / hormone supplement.
Typical adult dosage and time: Dose is tailored to blood levels following guidelines; high-dose treatment is followed by maintenance dosing.
Purpose: To maintain bone strength and lower fracture risk.
Mechanism: Improves calcium and phosphate balance and bone mineralization.
Main side effects: Very high doses can cause high calcium levels, leading to nausea, confusion, and kidney problems.

(Additional medicines such as other antidepressants, anti-seizure drugs, sleep aids, or treatments for specific complications may be used case-by-case. Choice always depends on individual assessment and up-to-date guidelines.)

Dietary molecular supplements

Evidence for supplements specifically in Charcot-Marie-Tooth disease–deafness syndrome is limited. Most data come from general nerve health or antioxidant studies. Supplements should not replace prescribed medicines, and doses should be decided with a doctor to avoid interactions.

1. B-complex vitamins (especially B1, B6, B12)
Description and function: B-vitamins support normal nerve function and energy production. Deficiency can itself cause neuropathy, so checking levels and supplementing when low is sensible in CMT.
Typical dosage: Often low-to-moderate daily doses based on lab tests and guideline ranges.
Mechanism: Support myelin maintenance, nerve signal transmission, and repair of nerve cells while preventing additional deficiency-related nerve damage.

2. Alpha-lipoic acid
Description and function: Alpha-lipoic acid is an antioxidant sometimes used in diabetic neuropathy. It may help reduce oxidative stress in nerves and slightly reduce pain in some people.
Typical dosage: Often 300–600 mg per day in studies, but doses should be individualized.
Mechanism: Acts as a free-radical scavenger and helps regenerate other antioxidants, potentially protecting nerve cells from oxidative injury.

3. Coenzyme Q10 (CoQ10)
Description and function: CoQ10 is involved in mitochondrial energy production. In theory it might support muscle and nerve energy in chronic neuromuscular conditions, although strong evidence is limited.
Typical dosage: Commonly 100–300 mg per day with food.
Mechanism: Supports mitochondrial ATP production and acts as an antioxidant, which may slightly improve fatigue in some people.

4. Omega-3 fatty acids (fish oil)
Description and function: Omega-3 fats from fish oil have anti-inflammatory properties and may support cardiovascular health and general cell membrane function.
Typical dosage: Often 1–2 g of EPA/DHA per day, adjusted for diet and bleeding risk.
Mechanism: Incorporated into cell membranes and reduce production of some inflammatory mediators, possibly easing musculoskeletal pain and supporting brain health.

5. Vitamin C
Description and function: Vitamin C is an antioxidant and is needed for collagen production. It has been studied in certain forms of CMT, though results are mixed and routine high-dose treatment is not recommended without supervision.Muscular Dystrophy Association
Typical dosage: Usually standard daily requirement unless a deficiency or specific protocol is used in research.
Mechanism: Antioxidant action and support of connective tissue might theoretically help maintain nerve and tendon health.

6. Vitamin E
Description and function: Vitamin E protects cell membranes from oxidative damage. Severe deficiency can cause neuropathy, so correcting low levels is important.
Typical dosage: Based on blood levels and total dietary intake.
Mechanism: Antioxidant protection of nerve cell membranes and myelin sheaths.

7. Magnesium
Description and function: Magnesium is important in nerve and muscle function. Low magnesium can worsen cramps and muscle irritability, so replacing deficiency may help symptoms such as leg cramps.
Typical dosage: Dose depends on age and renal function; excessive intake can be dangerous in kidney disease.
Mechanism: Regulates ion channels and muscle relaxation; adequate levels may lower cramp frequency.

8. N-acetylcysteine (NAC)
Description and function: NAC is a precursor to glutathione, a key antioxidant. It is used medically for other indications and studied in various neurodegenerative disorders.
Typical dosage: When used as a supplement, lower oral doses are chosen than in hospital treatments; this must be physician-guided.
Mechanism: Increases glutathione levels, which may help protect nerve cells from oxidative stress.

9. Curcumin (turmeric extract)
Description and function: Curcumin has anti-inflammatory and antioxidant effects in experimental studies and is sometimes taken for joint pain and general inflammation.
Typical dosage: Standardized extracts are used; exact dose should follow product and medical advice.
Mechanism: Modulates inflammatory signaling pathways and may reduce low-grade inflammation contributing to pain.

10. Resveratrol
Description and function: Resveratrol is a plant polyphenol that has antioxidant and possible neuroprotective effects in laboratory models. Human data in CMT are lacking.
Typical dosage: Doses vary; safety and interactions must be considered, especially with other medicines.
Mechanism: Influences cellular stress pathways and mitochondrial function, which might support general nerve health.

Regenerative, immune and stem-cell-related drugs and approaches

At present there are no FDA-approved stem cell or gene-replacement drugs specifically for Charcot-Marie-Tooth disease–deafness syndrome. Research is ongoing in areas such as gene therapy and cell-based therapies for inherited neuropathies and hearing loss, but these are experimental and usually available only in clinical trials.Orpha+2institut-myologie.org+2

Examples of research and supportive approaches (not standard drugs you can buy in a pharmacy) include:

Gene-replacement therapies being tested for certain CMT subtypes, where a working copy of a faulty gene is delivered to nerve cells using viral vectors.
Antisense oligonucleotide therapies designed to lower harmful over-expressed genes in some hereditary neuropathies.
Neurotrophic factors such as neurotrophin-3 investigated to support nerve survival.
Mesenchymal stem cell infusions researched as potential ways to release growth factors and modulate immune responses in neuropathies.
Inner-ear hair-cell regeneration drugs under study for sensorineural hearing loss in general.
Immune-modulating drugs (such as some monoclonal antibodies) used only if a person has an overlapping immune neuropathy or autoimmune disease, which is uncommon in pure genetic CMT-deafness.institut-myologie.org+1

All of these remain experimental; dosing and safety are determined only within controlled trials. Anyone interested should talk to a neurologist or geneticist about clinical trial registries rather than trying to access unregulated “stem cell clinics,” which can be unsafe.Muscular Dystrophy Association

Surgical treatments

1. Foot and ankle corrective surgery
Surgeons may correct severe foot deformities such as high arches, hammertoes, or twisted ankles that cause pain, ulcers, or repeated sprains. Operations can include tendon transfers, bone cuts (osteotomies), and joint fusions. The goal is a more stable, plantigrade foot that fits normal shoes and braces.Mayo Clinic+1

2. Tendon transfer procedures in the hand
If thumb or finger muscles are very weak, selected tendons can be re-routed to improve pinch or grip. This is considered when splints and therapy no longer give enough function.Muscular Dystrophy Association

3. Spine surgery
Some people with CMT develop scoliosis (curvature of the spine). If curves are severe and cause pain or breathing problems, spinal fusion surgery may be recommended, usually in adolescence.Muscular Dystrophy Association

4. Cochlear implant surgery
For severe to profound hearing loss where hearing aids do not give enough understanding of speech, cochlear implant surgery is a key option. Electrodes are placed in the inner ear and an external processor is worn behind the ear.Charcot-Marie-Tooth Association+1

5. Ear or skull-base procedures for auditory implants
In rare situations, when the auditory nerve itself is damaged, an auditory brainstem implant or other central device may be considered in specialized centers, mainly within research programs.institut-myologie.org

Prevention and lifestyle protection

Because this syndrome is genetic, we cannot fully “prevent” it. However, we can reduce complications and slow worsening:

Genetic counselling and informed family planning.
Avoiding known neurotoxic medications (certain chemotherapy agents, high-dose metronidazole, some older antibiotics) whenever safer alternatives exist.Muscular Dystrophy Association
Regular physical and occupational therapy to prevent contractures and maintain function.
Early and consistent use of braces and hearing devices to reduce falls and communication failures.Charcot-Marie-Tooth Association+2Charcot-Marie-Tooth Association+2
Routine foot and skin care to prevent ulcers and infections.Mayo Clinic+1
Fall-prevention strategies at home and school/work, including good lighting and rails.
Vaccination and prompt infection treatment, because infections can worsen weakness temporarily and increase hospitalizations.
Healthy weight control, since extra body weight increases stress on weak feet and joints.
Hearing protection, such as avoiding very loud music and using ear protection around noise to protect remaining hearing.Charcot-Marie-Tooth Association+1
Mental health support, which can prevent secondary problems like severe depression or substance misuse.Muscular Dystrophy Association

When to see doctors

You or your family should seek medical advice:

At first signs of muscle weakness, frequent tripping, toe-walking, or hand clumsiness, especially if there is a family history of CMT or deafness. Early diagnosis allows early support.Mayo Clinic+1
If hearing seems reduced, for example needing the television louder, misunderstanding speech in noise, or not responding to soft sounds. Early hearing tests and hearing aids or other options can protect learning and social development.Charcot-Marie-Tooth Association+1
When pain, cramps, or fatigue are strong enough to disturb sleep, school, work, or mood, because many treatments can help.Muscular Dystrophy Association
If you notice foot ulcers, blisters, or color changes that do not heal, as nerve damage means small injuries can become serious quickly.Mayo Clinic+1
If balance suddenly worsens, you have new falls, or you faint, which may signal treatable complications like orthostatic hypotension or other conditions.Muscular Dystrophy Association+1
If mood is low, anxiety is strong, or there are thoughts of self-harm. This is a medical emergency; it is important to talk to a trusted adult and a health professional immediately.Muscular Dystrophy Association+1

What to eat and what to avoid

In general, a balanced Mediterranean-style pattern is sensible:

What to focus on (10 key points)

Plenty of vegetables and fruits for vitamins, fiber, and antioxidants.
Whole grains (brown rice, oats, whole-wheat bread) for steady energy and bowel health.
Lean proteins (fish, poultry, beans, lentils) to support muscle maintenance.
Fatty fish (such as salmon or sardines) a few times a week for omega-3 fats.
Nuts and seeds in small portions for healthy fats and micronutrients.
Low-fat dairy or fortified alternatives to supply calcium and vitamin D.
Adequate fluids, mainly water, to support general health and prevent constipation.
Regular meals to maintain energy and avoid large blood sugar swings that increase fatigue.
Enough calories to avoid under-nutrition but not so many that weight gain strains weak legs.
Limited salt if blood pressure is high or midodrine or other medications complicate control.Mayo Clinic+1

What to limit or avoid

Very high-sugar foods and drinks that give short bursts of energy followed by fatigue.
Excess saturated and trans fats from fried and processed foods, which harm heart and blood vessels.
Heavy alcohol use, which is directly toxic to nerves and can worsen neuropathy and balance.
Crash diets or extreme supplement use without medical guidance, which can lead to vitamin or mineral deficiency.Muscular Dystrophy Association

Frequently asked questions (FAQs)

1. Can Charcot-Marie-Tooth disease–deafness syndrome be cured?
No. At present there is no cure that can reverse the underlying genetic problem or fully restore damaged nerves and hearing. However, many treatments—physical and occupational therapy, braces, hearing devices, pain medicines, and psychological support—can greatly improve daily life and independence. Research into gene therapy and regenerative approaches is active, and future treatments may be more powerful.Orpha+2institut-myologie.org+2

2. Will everyone with this syndrome end up in a wheelchair or completely deaf?
Severity is highly variable. Some people have mild weakness and moderate hearing loss, while others are more severely affected. Early support, good bracing, safe exercise, and timely hearing interventions can delay or sometimes avoid wheelchair use and help people communicate well even if hearing becomes very limited.Orpha+2Mayo Clinic+2

3. Is it safe to exercise if I have CMT-deafness?
In most cases, properly supervised, moderate exercise is safe and recommended. Over-exertion or high-impact sports may cause injuries, so exercise plans should be designed with a physical therapist who understands neuromuscular disease. Water-based exercise or cycling are often good choices.Mayo Clinic+1

4. Will hearing aids really help if the problem is in the nerve?
Even when the auditory nerve is affected, many people gain useful benefit from modern digital hearing aids or remote microphones, especially in classrooms and meetings. If hearing aids are no longer helpful, cochlear implants or other devices may be discussed with a specialist.Charcot-Marie-Tooth Association+1

5. Is this syndrome always inherited from a parent?
Often, the gene change is inherited, but sometimes a new (de novo) mutation appears for the first time in a child. Genetic testing and counselling can explain the pattern in each family and clarify the risk for siblings or future children.Orpha

6. Should children with this syndrome attend regular school?
Most children can attend regular school with appropriate supports such as hearing technology, classroom seating adjustments, extra time for tasks, and sometimes a teaching assistant. Early involvement of school services and clear communication about needs is important.Charcot-Marie-Tooth Association+1

7. What about pregnancy and childbirth?
Many people with CMT can have healthy pregnancies, but there may be increased risk of falls, fatigue, or delivery difficulties if leg weakness is severe. Pre-pregnancy counselling with neurology, genetics, and obstetrics teams is recommended.Orpha+1

8. Are everyday supplements like multivitamins enough?
For many people, a balanced diet plus a standard multivitamin is enough. Extra supplements should be guided by blood tests and medical advice to avoid overdose or interactions with medicines.Muscular Dystrophy Association

9. Can loud noise make my hearing loss worse?
Yes. People with sensorineural hearing loss should protect their ears from very loud noise, as remaining hair cells and nerve fibers are more vulnerable. Using ear protection at concerts or noisy workplaces is important.Charcot-Marie-Tooth Association+1

10. How often should I see specialists?
Most people benefit from yearly or twice-yearly reviews by a neurologist and audiologist, with more frequent visits during periods of change or after surgery or device fitting. Therapists may be seen more often during active rehabilitation.Mayo Clinic+1

11. Is CMT-deafness syndrome life-threatening?
The condition mainly affects quality of life rather than lifespan for many people, but some can have complications such as severe scoliosis, falls, or breathing problems if respiratory muscles are involved. Careful monitoring and early treatment of complications improve long-term outlook.Orpha+1

12. Are there special risks with anesthesia or surgery?
Certain anesthetic drugs and positions during surgery may pose extra risks in neuromuscular disease, so it is essential that anesthesiologists know about the diagnosis. Pre-operative assessment and careful monitoring reduce risk.Muscular Dystrophy Association

13. Can hearing loss improve over time?
In a genetic neuropathy, hearing loss usually does not spontaneously improve, but hearing function may feel better with training, hearing aids, or implants. Sudden changes in hearing should always be checked quickly, as they might have other causes.Charcot-Marie-Tooth Association+1

14. Is it useful to join research studies?
Clinical trials and registries help researchers understand the natural history of this rare syndrome and test potential treatments. Participation can offer access to cutting-edge care but also involves risks and commitments, so decisions should be made after discussion with the research team.Orpha+1

15. What is the most important message for families?
The most important message is that, although the genetic cause cannot yet be removed, early, coordinated, and continuous care can make a big difference. Combining physical and occupational therapy, good bracing and hearing management, mental health support, and informed lifestyle choices allows many people with Charcot-Marie-Tooth disease–deafness syndrome to lead rich, meaningful lives.Muscular Dystrophy Association+3Orpha+3Mayo Clinic+3

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.